TAT opens the door

Molecular Therapy

Volumn 16, Issue 4, 2008, Pages 647-648

  Vyas, Piyush M ^a   Payne, Ronald M ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOACID DEHYDROGENASE; DIHYDROLIPOAMIDE DEHYDROGENASE TRANSACTIVATOR PROTEIN; HYBRID PROTEIN; UNCLASSIFIED DRUG;

BLOOD BRAIN BARRIER; CELL BASED GENE THERAPY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; ENZYME REPLACEMENT; GENE DELETION; GENETIC TRANSDUCTION; HUMAN; MITOCHONDRIAL MEMBRANE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NOTE; NUCLEAR LOCALIZATION SIGNAL; PHENOTYPE; POINT MUTATION; PROTEIN PROCESSING; PROTEIN TARGETING;

EID: 41149118540     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2008.24     Document Type: Note

References (21)

1. Wallace, DC (1999). Mitondrial diseases in man and mouse. Science 283: 1482-1488.
2. Neupert, W and Hemmann, JM (2007). Translocation of proteins into mitochondria. Annu Rev Biochem 76: 723-749.
3. Begley, DJ (1996). The blood-brain barrier principles for targeting peptides and drugs to the central nervous system. J Pharm Pharmacol 48: 136-146.
4. Haas, RH (2007). The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease. Mitochondrion 7 (Suppl): S136-S145.
5. Gillingham, MB, Scott, B, Elliott D and Harding, CO (2006). Metabolic control during exercise with and without medium-chain triglycerides (MCT) in children with long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency. Mol Genet Metab 89: 58-63.
6. Rapoport, M, Saada, A, Elpeleg, O, and Lorberboum-Galski, H (2008). TAT-mediated delivery of LAD restores pyruvate dehydrogenase complex activity in-mitochondria of LAD deficient patients. Mol Ther 16 xxx-xxx. [6300410]
7. Brautigam, CA, Chuang, JL, Tomchick; DR, Machius, M and Chuang, DT (2005). Crystaf structure of human dihydrolipoamide dehydrogenase: NAD+/ NADH binding and the structural basis of disease-causing mutations. J Mol Biol 350: 543-552.
8. Chinnery, PF and Schon, EA (2003). Mitochondria. J Neurol Neurosurg Psychiatr 74: 1188-1199.
9. Saada, A, Aptowitzer, I, Link, G and Elpeleg, ON (2000). ATP synthesis in lipoamide dehydrogenase deficiency. Biochem Biophys Res Commun 269: 382-386.
10. Shaag, A, Saada, A Berger, I, Mandel, H, Joseph, A, Feigenbaum, A et al. (1999). Mo1ecular basis of lipoamide dehydrogenase deficiency in Ashkenazi Jews. Am J Med Genet 82: 177-182.
11. Schwarze, S R, Ho, A, Vocero-Akbani, A and Dowdy, SF (1999). In vivo protein transduction: Delivery of a biologically acWe protein into the mouse. Science 285: 1569-1572.
12. Del Gaizo, V, MacKenzie, JA and Payne, RM (2003). Targeting proteins to mitochondria using TAT. Mol Genet Metab 80: 170-180.
13. Gustafsson, A B, Gottlieb, RA and Granville, DJ (2005). TAT-mediated protein transduction: Delivering biologically active proteins to the heart. Methods Mol Med 112: 81-90.
14. Drin, G, Cottin, S, Blanc, E, Rees, 'AR and Temsamani, J (2003). Studies on the internalization mechanism of cationic cell-penetrating peptides. J Biol Chem 278: 31192-31201.
15. Toro, A and Grunebaum, E (2006). TAT-mediated intracellular delivery of purine nucleoside phosphorylase correts its deficiency in mice. J Clin Invest 116: 2717-2726.
16. Ryser, H J, Drummond, I and Shen, WC (1982). The cellular uptake of horseradish peroxidase and its poly(lysine) conjugate by cultured fibroblasts is qualitatively similar despite a 900-fold dffference in rate. J Cell Physiol 113: 167=178.
17. Mitchell, DJ, Kim, DT, Steinman L, Fathman, CG and Rothbard,,JB (2000). Polyarginine enters cells more efficiently than other polycationic: homopolymers. J Pept Res 56: 318-325.
18. Levin, VA (1980) Relationship 4 octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J Med Chem 23: 682-684.
19. Gaume, B, Klaus, C, Ungermann, C, Guiard, B, Neupert, W and Brunner, M (1998). Unfoldirig of preproteins upon import iito mitochondria. EMBO J 17: 6497.
20. Del Gaizo, V and, Payne, RM(2003). A novel TAT-mitochondrial signal sequence fusion protein is processed, stays in mitochondria, and crosses the placenta. Mol Ther 7: 720-730.
21. Cao, C, Pei, W, Ge, H, Liang, Q, Luo, Y, Sharp, FR et al. (2002). In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against isthemic braid injury and neumnal apoptosis. J Neurosci 22: 5423-5431.